Simon King's profile photo

Simon King

England, London

Editor-in-Chief at FirstWord Pharma

Executive editor at FirstWord Pharma

Articles

  • May 30, 2024 | onlinelibrary.wiley.com | Seyma S. Celina |Simon King |Martin Ashby |Katie Harris

    Conflicts of Interest The authors declare that they have no conflicts of interest. References 1 , , , , , , , , , , and , Identification and characterization of a novel non-structural protein of bluetongue virus, PLoS Pathogens. (2011) 7, no. 12, e1002477, https://doi.org/10.1371/journal.ppat.1002477, 2-s2.0-84855257695. 2 , , , , , , , , , , , and , Characterization of a second open reading frame in genome segment 10 of bluetongue virus, Journal of General Virology. (2015) 96, no.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
56
Tweets
3
DMs Open
No
FW Simon King
FW Simon King @SimonWKing
23 Apr 12

Better than expected price for PFE's nutritionals + animal health spin-out= up to 15% reduction in # of shares say ISI analysts

FW Simon King
FW Simon King @SimonWKing
23 Apr 12

AMGN Q1 earnings should be interesting later today - particularly incoming competition from AFFY's Omontys in ESA space

FW Simon King
FW Simon King @SimonWKing
23 Apr 12

Looks like AZN sticking to their guns on the 'bolt on' M&A front http://t.co/OOxUI587 - enough of these buys out there?